AGM this Friday. As I already posted they said they are financed25 Jun 2023 13:53
Until H2 2024. They have also made it quite clear that they are not expecting the main profit drivers to kick in until around the end of the year and start of next. So as far as raising money goes it seems to me they are probably looking at sometime early 2024. I presume by then the sp will be at least a lot closer to last July's placing price of ***80p*** a share. Note the sp finished at 12.5 p to buy at close of play Friday, having bounced off the low of 11.5p earlier that day.
I believe the market is looking only for steady progress. The Bioview HER2 ASSAY DEVELOPMENT PARTNERSHIP announced 19th April clearly is a potential MAJOR PROFIT MAKER for next year.
I still believe they will get a bid. The tech simply needs time and investment and I expect a foreign pharma Co. (USA, Japan?) to snap them up. Sell and you could well be kicking yourself here IMHO.
It's sad UK Co's come up with such good products that are often bought on the cheap by foreign Co's.
Maybe last Fridays sp dip will trigger an offer. As things go maybe 40p a share would be accepted?
All IMHO.